Sørlandet Hospital
Kristiansand, 4626, Norway
NCT Number: NCT05093777
By longitudinal, prospective research in children with neurodisabilities including severe motor impairments and their parents to explore the beneficial effects of participating in an intensive habilitation program on the child's adaptive functioning and parental empowerment in order to treat and reduce the consequences of early brain damage.
Looking for future studies?
Notify Me2 year–7 year
All sexes
Interventional
Not applicable
Kristiansand, 4626, Norway
Evidence-based knowledge about the effects of intensive training programs for children with severe early brain damage is limited since research on this topic has methodological weaknesses and shows conflicting results. As intensive training programs require extensive efforts from the child, parents and professionals and represent major costs, the importance of scientifically proven effects is considerable. This research project aims to measure the effects of an intensive habilitation program for young children with severe early brain damage on the child's adaptive, motor, language and social functioning and on parental empowerment, family functioning and stress. In this randomized controlled trial (RCT) 90 children will be divided into an intervention group participating in a Norwegian developed program of intensified habilitation of 12 months duration and a control group, who will receive "services as usual" during the same time period. Between-group analyses will then be performed. Due to a stepped wedge design, the control participants will then be offered training in year two of participation. Within-group analysis of results before and after training will then be performed for all participants. Standardized measures with high responsiveness in documenting intervention effectiveness will be used as primary outcome measures. Intensive training groups will be offered in all Health Regions in Norway and if successful be implemented as standard clinical practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The program is based on a holistic and family-centered concept, which acknowledges parents as experts on their child's abilities and needs. The program involves both parents and local professionals, and includes goal setting and goal-directed treatment targeted to the needs of the individual child. The program lasts for about one year and contains three in-patient group sessions over 2 weeks. In between the children are receiving individualized home training programs at home and in pre-school/kindergarten. The children train on a daily basis, both during the inpatient sessions and in the home setting.
Other names: PIH Multi
When the participants are not joining the study year containing the intervention program, they will be offered habilitation services "as usual" administered by the primary health care services in the local community.
Other names: Control
Time frame: Change from baseline measure at 12 months and after 24 months
Primary evaluation measure for the child
Time frame: Change from baseline measure at12 months and after 24 months
Primary evaluation measure for the parents
Time frame: Change from baseline measure at 12 months and after 24 months
Secondary evaluation measure for the child
Time frame: Change from baseline measure at 12 months and after 24 months
Secondary evaluation measure for the parents
Sorlandet Hospital HF
Other Gov
Evaluation of a Norwegian Model of an Intensive Habilitation Program for Young Children With Early Brain Damage - a Multicentre Randomized Controlled Trial.
Acronym: PIHMulti
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05473676
Brain Damage, Chronic, Brain Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT00975338
Brain Damage, Chronic, Brain Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02592291
Brain Damage, Chronic, Brain Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06111898
Brain Damage, Chronic, Brain Diseases
Geneva, Switzerland
View Trial Details